Cargando…

Risk factors for long-term survival in patients with ypN+ M0 rectal cancer after radical anterior resection

BACKGROUND: Regional lymph node metastases are the main adverse prognostic factor in patients with rectal cancer without distant metastases. There are discrepancies, however, regarding additional risk factors in the group of ypN + M0 patients. The purpose of the study was to assess clinical and path...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeman, Marcin, Skałba, Władysław, Szymański, Piotr, Hadasik, Grzegorz, Żaworonkow, Dmytro, Walczak, Dominik A., Czarniecka, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961971/ https://www.ncbi.nlm.nih.gov/pubmed/35346064 http://dx.doi.org/10.1186/s12876-022-02226-9

Ejemplares similares

The assessment of risk factors for long-term survival outcome in ypN0 patients with rectal cancer after neoadjuvant therapy and radical anterior resection
por: Zeman, Marcin, et al.
Publicado: (2021)

Tumor budding outperforms ypT and ypN classification in predicting outcome of rectal cancer after neoadjuvant chemoradiotherapy
por: Trotsyuk, Iryna, et al.
Publicado: (2019)

Selective use of adjuvant chemotherapy for rectal cancer patients with ypN0
por: You, Kai-yun, et al.
Publicado: (2014)

Nomogram to predict ypN status after chemoradiation in patients with locally advanced rectal cancer
por: Jwa, E, et al.
Publicado: (2014)

Are you treating ypN0 patient with adjuvant abemaciclib?
por: Toss, A., et al.
Publicado: (2023)

Impact of renin-angiotensin system inhibitors on the survival of patients with rectal cancer
por: Zeman, Marcin, et al.
Publicado: (2022)

Impact of adjuvant chemotherapy on patients with ypT0–2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital
por: Galata, Christian, et al.
Publicado: (2018)

Assessment of the risk of permanent stoma after low anterior resection in rectal cancer patients
por: Zeman, Marcin, et al.
Publicado: (2020)

Fat clearance and conventional fixation identified ypN0 rectal cancers following intermediate neoadjuvant radiotherapy have similar long-term outcomes
por: Chen, Nan, et al.
Publicado: (2019)

Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer
por: Fukada, Ippei, et al.
Publicado: (2016)

The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes
por: Cho, Won Kyung, et al.
Publicado: (2019)

The role of postmastectomy radiation in patients with ypN0 breast cancer after neoadjuvant chemotherapy: a meta-analysis
por: Wang, Ke, et al.
Publicado: (2021)

The prognostic differences and the effect of postmastectomy radiotherapy between post‐chemotherapy ypT1‐2ypN1 and de novo pT1‐2N1 breast cancer
por: Yang, Tian, et al.
Publicado: (2023)

Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved
por: Liu, Zining, et al.
Publicado: (2021)

Treatment of Oesophagojejunostomy Leakage With the Use of Fibrin Glue: Case Report
por: Skałba, Władysław, et al.
Publicado: (2022)

Axillary response and outcome in breast cancer patients after neoadjuvant treatment: The role of radiotherapy in reducing recurrence in ypN0 patients with initially cN+ stage
por: Ren, Xiaoqiu, et al.
Publicado: (2023)

Comparison between Local Excision and Radical Resection for the Treatment of Rectal Cancer in ypT0-1 Patients: An Analysis of the Clinicopathological Factors and Survival Rates
por: Oh, Soo Young, et al.
Publicado: (2021)

Prediction of Advanced Axillary Lymph Node Metastases (ypN2-3) Using Breast MR imaging and PET/CT after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma Patients
por: Kim, Won Hwa, et al.
Publicado: (2018)

The impact of postmastectomy radiotherapy on cT1-2N1 breast cancer patients with ypN0 after neoadjuvant chemotherapy: a retrospective study based on real-world data
por: Dai, Yuran, et al.
Publicado: (2023)

Postoperative radiotherapy improves survival of patients with ypN2 non‐small cell lung cancer after neoadjuvant chemotherapy followed by surgery – A propensity score matching study of the Surveillance, Epidemiology, and End Results database
por: Bao, Yongxing, et al.
Publicado: (2021)

Impact of Adjuvant Chemotherapy Completion on Oncologic Outcomes in ypTNMstage 2 Rectal Cancer Patients
por: Park, Youn Young, et al.
Publicado: (2019)

Stratified Prognostic Value of Pathological Response to Preoperative Treatment in yp II/III Rectal Cancer
por: Yang, Yanpeng, et al.
Publicado: (2021)

Monthly tegafur–uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study
por: Kuo, Yi-Hung, et al.
Publicado: (2019)

Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)

Significance of ypTNM stage in determining the prognosis and therapy after surgery for locally advanced rectal cancer
por: Chen, Yue, et al.
Publicado: (2023)

Reply to Hsueh YP et al.
por: Nambot, Sophie, et al.
Publicado: (2020)

Factors influencing anterior/low anterior resection syndrome after rectal or sigmoid resections
por: BENLİ, Sami, et al.
Publicado: (2021)

Is adjuvant chemotherapy necessary for patients with ypT0–2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery?
por: Lu, Zhao, et al.
Publicado: (2018)

The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy
por: Cui, Jian, et al.
Publicado: (2017)

Impact of rectal washout on recurrence and survival after anterior resection for rectal cancer
por: Svensson Neufert, Rebecca, et al.
Publicado: (2022)

YpT1-2N0 rectal cancer after neoadjuvant chemoradiation has lower survival compared with pT1-2N0 rectal cancer
por: Wan, Jue-feng, et al.
Publicado: (2015)

Prediction of anastomotic leakage after anterior rectal resection
por: Cheng, Shubang, et al.
Publicado: (2019)

Deep Learning-Based Yoga Posture Recognition Using the Y_PN-MSSD Model for Yoga Practitioners
por: Upadhyay, Aman, et al.
Publicado: (2023)

Complete pathological response (ypT0N0M0) after preoperative chemotherapy alone for stage IV rectal cancer
por: Naiken, Surennaidoo P, et al.
Publicado: (2014)

Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
por: Kim, Chang Gon, et al.
Publicado: (2017)

Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy
por: Cui, Jian, et al.
Publicado: (2019)

Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis
por: Jung, Sung Min, et al.
Publicado: (2016)

Management of Low Anterior Resection Syndrome (LARS) Following Resection for Rectal Cancer
por: Rosen, Harald, et al.
Publicado: (2023)

Laparoscopic low anterior resection for rectal cancer with rectal prolapse: a case report
por: Yamamoto, Ryusei, et al.
Publicado: (2018)

Rectal washout does not increase the complication risk after anterior resection for rectal cancer
por: Teurneau-Hermansson, Karl, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_silcrkjbj86mrdke75brtpjqm9